• Home
  • About
  • Repositories
  • Search
  • Web API
  • Feedback
<< Go Back

Metadata

Name
Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
Repository
ClinicalTrials.gov
Identifier
clinicaltrials:NCT00294190
Description
This proposed phase II trial will investigate weekly topotecan at a higher dose than was used
in the previous trials in an attempt to achieve improved response rates and disease control
without added toxicity. To help ameliorate the fatigue, planned rest weeks will be
incorporated into the schedule. This trial will be the first clinical trial to evaluate a
higher dose of weekly topotecan in the treatment of extensive-stage SCLC.
Data or Study Types
clinical trial
Keywords
Small Cell Lung Cancer, Lung Cancer, Extensive stage
Source Organization
Unknown
Access Conditions
available
Year
2006
Access Hyperlink
https://clinicaltrials.gov/ct2/show/NCT00294190

Distributions

  • Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT00294190
trialweeklytopotecanhigherproposedphaseusedrates
This project was funded in part by grant U24AI117966 from the NIH National Institute of Allergy and Infectious Diseases as part of the Big Data to Knowledge program. We thank all members of the bioCADDIE community for their valuable input on the overall project.